Wegovy-maker Novo Nordisk to cut around 9,000 jobs

Core Viewpoint - Novo Nordisk is undergoing a company-wide transformation aimed at simplifying its organization, enhancing decision-making speed, and reallocating resources towards growth opportunities in diabetes and obesity treatments [1] Group 1: Workforce Reduction - The company plans to cut approximately 9,000 roles from its global workforce of 78,400 positions [1] - Around 5,000 of these reductions are expected to occur in Denmark [1]